Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VTP-1000 by Barinthus Biotherapeutics for Celiac Disease: Likelihood of Approval
VTP-1000 is under clinical development by Barinthus Biotherapeutics and currently in Phase I for Celiac Disease. According to GlobalData, Phase...
VTP-500 by Barinthus Biotherapeutics for Middle East Respiratory Syndrome (MERS): Likelihood of Approval
VTP-500 is under clinical development by Barinthus Biotherapeutics and currently in Phase I for Middle East Respiratory Syndrome (MERS). According...
VTP-200 by Barinthus Biotherapeutics for Cervical Cancer: Likelihood of Approval
VTP-200 is under clinical development by Barinthus Biotherapeutics and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...
VTP-200 by Barinthus Biotherapeutics for Cervical Intraepithelial Neoplasia (CIN): Likelihood of Approval
VTP-200 is under clinical development by Barinthus Biotherapeutics and currently in Phase II for Cervical Intraepithelial Neoplasia (CIN). According to...
VTP-200 by Barinthus Biotherapeutics for Human Papillomavirus (HPV) Associated Cancer: Likelihood of Approval
VTP-200 is under clinical development by Barinthus Biotherapeutics and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer. According...